Best Healthcare Companies in Australia
The 1366 best Healthcare companies in Australia in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Mesoblast.
Australia's Healthcare sector is bigger and stranger than most people realise, and this directory ranks the best Healthcare companies across Australia by disclosed equity funding and recent funding momentum. We're tracking 1,366 companies with $4.2B in total disclosed funding, and the spread tells you a lot: Mesoblast sits at $980M, Aidacare at $382M, and then the curve drops fast to single-digit millions for names like More Good Days and MindBio Therapeutics.
The global picture gives that spread some context. The market hit roughly $2T in 2020 and is forecast to reach $2.6T by 2025 at a 6.3% CAGR, driven by virtual touchpoints and shifting consumer expectations around affordability. Median app install growth across healthcare categories is running at +16% YoY, so digital access is clearly where patient behavior is moving. Hot deal themes right now cluster tightly around vaccine candidates and immunogenicity trials, which I'd expect to pull more capital toward biotech plays in the next few quarters. Strict product safety compliance remains a structural reality here, and if you're evaluating companies in this space, that regulatory weight is built into every funding timeline you'll see.
- Healthcare Consumers in Asia-Pacific Prefer a Single Touchpoint
- Global Healthcare to Soar Above $2 Trillion in 2020 with Consumerism a
Ranked: Best Healthcare companies in Australia
| # | Company | Disclosed funding | Last round | Stage | Employees | Founded | Tech stack | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Mesoblast Biotherapeutics derived from proprietary adult stem cell-based technologies | $980M | 17 mo ago | Public | 83 | 2004 | DrupalPHPAmazon Web Services+19 | 25 signals ▲178% Acquisition · Earnings · Funding | 70 patents Regenerative cell therapies using adult multipotent stem cells for neurological and musculoskeletal disorders | — |
| 2 | Sonic Healthcare Chain of pathology and radiology labs | $792M | 88 mo ago | Public | 41,000 | 1987 | Apple iCloud MailBootstrapAmazon Web Services+9 | 5 signals ▼29% Leadership · Acquisition | — | — |
| 3 | Affinity Health Healthcare organization focused on improving the quality of healthcare services | $667M | 267 mo ago | Acquired | — | 2003 | — | — | — | — |
| 4 | Aidacare Leading provider of healthcare equipment and assistive technology | $382M | 3 mo ago | Acquired | 900 | 1987 | WordPressApple iCloud MailMicrosoft 365+41 | — | — | 1 award |
| 5 | GenesisCare Chain of multi-speciality clinics | $273M | 84 mo ago | Series D | 5,500 | 2004 | Adobe Experience ManagerApple iCloud MailMicrosoft 365+30 | — | — | — |
| 6 | Mayne Pharma Drug delivery systems | $125M | 49 mo ago | Acquired | 160 | 1845 | WordPressApple iCloud MailMySQL+27 | 12 signals ▲71% M&A · Regulatory · Board | 100 patents Hedgehog pathway inhibitor drugs for proliferative disorders, especially skin cancers | — |
| 7 | Back2Work Organisation focused on providing disability employment services | $118M | 67 mo ago | Late Stage | — | 2013 | WordPressMySQLPHP+10 | — | — | — |
| 8 | 4DMedical Manufacturer of respiratory imaging and ventilation analysis equipment | $115M | 4 mo ago | Public | 141 | 2012 | WordPress Block EditorElementorWordPress+27 | 3 signals Funding · Capital raise | 33 patents AI-driven pulmonary imaging and functional assessment for diagnosis and treatment monitoring | — |
| 9 | Botanix Pharma Developer of dermatology treatments for underserved skin diseases | $91M | 13 mo ago | Acquired | 7 | 1984 | WordPressMySQLPHP+20 | 5 signals Capital raise · Earnings | — | — |
| 10 | Arabella Manufacturer of anti-aging cosmetics and wound care products | $87M | 34 mo ago | Funding Raised | — | 2022 | — | — | — | — |
| 11 | Paradigm Biopharma Repurposing pentosan polysulphate sodium (PPS) for new orthopaedic and respiratory applications. | $71M | 74 mo ago | Public | — | 2014 | WordPressMySQLPHP+21 | — | — | 1 launch |
| 12 | Myhealth Chain of medical centers | $63M | 64 mo ago | Series C | 800 | 2007 | UmbracoApple iCloud MailMicrosoft 365+18 | — | — | — |
| 13 | Paragon Care Diversified medical devices distributor | $59M | 100 mo ago | Public | 508 | 1994 | DrupalApple iCloud MailMicrosoft 365+22 | — | — | 9 job openings |
| 14 | Vision Eye Institute Chain of eye care hospitals | $58M | 130 mo ago | Acquired | 201 | 1990 | WordPressMySQLPHP+31 | — | — | — |
| 15 | Immuron Developer of oral immunotherapy utilizing polyclonal antibody products | $37M | 70 mo ago | Public | 6 | 1994 | Cart FunctionalityWooCommerceWordPress+19 | 5 signals Earnings · New product | 79 patents Bovine hyperimmune colostrum therapeutics for bacterial and viral gastrointestinal infections | 1 launch |
| 16 | Biointelect Market evaluation and strategy design for biopharma, medical device and IVD companies | $33M | 11 mo ago | Funding Raised | 26 | 2011 | WordPressMySQLSalesforce+27 | — | — | 1 job opening |
| 17 | MorphImmune R&D company manufacturing drugs for multiple therapeutic areas | $32M | 37 mo ago | Series B | 11 | 2020 | — | — | — | — |
| 18 | VALD Provider of human measurement technology, clinic, and health online webinar services | $25M | 20 mo ago | Series B | 95 | 2015 | ContentfulSentryProton Mail+29 | — | — | 1 launch |
| 19 | Kismet Foundation focused on providing of accessible healthcare services | $24M | 21 mo ago | Seed | 12 | 2023 | Apple iCloud MailMicrosoft 365Node.js+20 | — | — | — |
| 20 | QRxPharma Provider of top 40 radio broadcasting services | $17M | 150 mo ago | Series A | 12 | 2002 | — | — | 45 patents Abuse‑deterrent solid dosage forms, sequential opioid delivery, and safe drug disposal devices | — |
| 21 | Heidi Developer of an AI assistant designed for clinical documentation support 78AI top 20%Tech top 24%Talent top 28%Funding top 30% All 10 signals ▾AItop 20% Techtop 24% Talenttop 28% Fundingtop 30% Customerstop 33% Growthtop 35% Moattop 42% Producttop 46% Marketbottom 45% Globalbottom 38% AI: Classified as an AI company Tech: 59 technologies across 5/8 capability areas · Cloud: Amazon Cloudfront, Amazon Web Services rank vs industry peers · Fliar Intelligence Index 78/100 | $15M | 8 mo ago | Series B | — | 2019 | SanitySentryApple iCloud Mail+31 | — | — | — |
| 22 | MCRI Center for research in child health | $12M | 89 mo ago | Series A | 1,266 | 1986 | JoomlaApple iCloud MailPHP+18 | — | — | — |
| 23 | Planet Innovation Provider of end-to-end healthtech product development and manufacturing services | $10M | 66 mo ago | Series A | 500 | 2009 | WordPressMySQLPHP+23 | — | 10 patents Automated cytopathology sample prep, staining instruments, and AI image analysis | — |
| 24 | Althea Company Producer, supplier, and exporter of pharmaceutical grade medicinal cannabis | $8M | 57 mo ago | Public | 59 | 2017 | WordPress Block EditorWordPressMySQL+23 | — | — | — |
| 25 | Vitable Manufacturer of vitamins and health supplements | $7M | 38 mo ago | Series A | 10 | 2019 | Cart FunctionalityShopifyReact+37 | — | — | — |
| 26 | Atmo Biosciences Swallowable sensors for profiling intestinal gases | $7M | 32 mo ago | Series B | 31 | 2017 | — | — | 21 patents Ingestible capsule sensors for gastrointestinal diagnostics and targeted therapeutic delivery | 1 award |
| 27 | IDT Australia IDT Australia Ltd produces, develops, and supplies pharmaceutical products. | $6M | 126 mo ago | Public | 55 | 1975 | WordPressMySQLPHP+18 | — | — | — |
| 28 | BioCina CDMO offering microbial expression systems-based biologics development and manufacturing services | $6M | 37 mo ago | Funding Raised | 58 | 2018 | WordPressMySQLPHP+25 | — | — | 1 partnership |
| 29 | Montu Manufacturer & supplier of cannabinoid products | $6M | 54 mo ago | Series A | 21 | 2019 | Wix eCommerceWixSentry+25 | — | — | 2 awards |
| 30 | Neo-Bionica Company specializing in the development of medical device prototypes for targeted therapies and diagnostics | $5M | 25 mo ago | Series A | 19 | 2021 | Framer SitesReactPriority Hints+7 | — | — | 1 launch |
| 31 | Invex Therapeutics Manufacturer of CNS therapeutic drugs | $5M | 72 mo ago | Public | 11 | 2019 | — | — | 20 patents Therapeutics for ocular and intracranial hypertension using peptide-based drug formulations. | — |
| 32 | Nutrition Innovation Food production technology company | $5M | 87 mo ago | Series A | 9 | 2017 | — | — | — | — |
| 33 | More Good Days Provider of pain education and self-management strategy services | $4M | 0 mo ago | Series A | — | 2015 | WebflowSentryAmazon Web Services+19 | — | — | 1 job opening |
| 34 | Microbio Manufacturer of PCR test kits | $4M | 42 mo ago | Seed | 19 | 2018 | WordPressApple iCloud MailMicrosoft 365+29 | — | — | — |
| 35 | Fiji Kava Producer of kava-based relaxation and sleep products | $3M | 69 mo ago | Public | — | 2013 | Shogun Page BuilderCart FunctionalityShopify+29 | — | — | — |
| 36 | Navigator Group Provider of physical & mental recovery and injuries treatment services | $3M | 38 mo ago | Series A | 32 | 2018 | Cart FunctionalitySquarespace CommerceSquarespace+21 | — | — | — |
| 37 | MindBio Therapeutics Provider of phase I & II clinical trial services for mental health diseases | $3M | 2 mo ago | Public | 18 | 2021 | Cart FunctionalitySquarespace CommerceSquarespace+12 | 5 signals ▼38% Announcements · New product · Funding | — | 4 launchs |
| 38 | Avicena Systems Developer of biosecurity platform and hardware for pathogen testing | $3M | 28 mo ago | Funding Raised | 20 | 2020 | — | — | 22 patents High-throughput bioassay and pathogen/genetic screening instrumentation | 1 partnership |
| 39 | Trioda Wilingi Manufacturer of injectables medical gels | $3M | 39 mo ago | Seed | — | — | — | — | — | — |
| 40 | OneMRI Provider of whole-body magnetic resonance imaging scans and medical reviews | $2M | 10 mo ago | Seed | — | 2024 | WebflowApple iCloud MailGoogle Workspace+21 | — | — | — |
| 41 | ANDHealth Association focused on development, commercialization & implementation of digital health technologies | $1M | 43 mo ago | Seed | — | 2017 | — | 3 signals Leadership · Funding | — | — |
| 42 | BioFoundry Molecular biology laboratory | $1M | 18 mo ago | Seed | — | 2014 | — | — | — | — |
| 43 | Turnto Provider of academic medical literature translation services | $1M | 38 mo ago | Seed | 10 | 2021 | WebflowSlickjQuery+11 | — | — | — |
| 44 | Eudaemon Technologies Provider of medical device outsourcing services | $942K | 43 mo ago | Funding Raised | — | 2018 | — | — | — | — |
| 45 | ResusRight Manufacturer of medical devices to prevent the death and disability of newborn babies | $784K | 38 mo ago | Seed | 10 | 2020 | — | — | — | — |
| 46 | Kite Therapy Early childhood therapy company providing transdisciplinary therapy for children with autism and… | $750K | 25 mo ago | Seed | — | 2023 | — | — | — | — |
| 47 | Smart MCs Smart biomaterials and microfluidic solutions provider for bioproduction | $600K | 37 mo ago | Funding Raised | 2 | 2022 | — | — | — | — |
| 48 | VeinTech Manufacturer of cannulation products | $493K | 38 mo ago | Funding Raised | — | 2020 | — | — | — | 1 partnership · 1 expansion |
| 49 | Go Locum Provider of healthcare staffing services | $350K | 23 mo ago | Seed | 4 | 2021 | Node.jsFirebaseBootstrap+16 | — | — | — |
| 50 | Lactamo Manufacturer of soft sphere for breastfeeding | $237K | 28 mo ago | Funding Raised | 1 | 2019 | Cart FunctionalityShopifyVisa+21 | — | — | 1 award |
Top 12 Healthcare companies in Australia
#1
Acquired · Sydney, New South Wales · founded 1987 · 900 employees$382Mraised▾
Leading provider of healthcare equipment and assistive technology. The company offers a wide range of products for hospitals, residential aged-care facilities, home and community care, and rehabilitation settings. Their comprehensive catalog includes bathroom and toilet aids, bedroom furniture, mobility solutions, pressure care products, and manual handling equipment. They also provide services such as maintenance, repair, and facility fitouts. A focus on product quality and ongoing support ensures trusted brands and strong relationships with healthcare providers. The company works closely with healthcare professionals to provide expert guidance and solutions tailored to individual needs, improving the quality of life for patients and clients. They offer a variety of solutions across different care settings, from individual home use to large-scale hospital deployments. Commitment to ongoing support and service ensures clients receive the best possible care and equipment solutions.
- Feb 2026Conventional Debt$382M
#2
Public · Melbourne, Victoria · founded 2012 · 141 employees$114.8Mraised▾
Manufacturer of respiratory imaging and ventilation analysis equipment
- Jan 2026Post IPO$100.5M
- Jul 2023Grant (prize money)$740K
- May 2023Post IPO$13.6M
#3
Public · Melbourne, Victoria · founded 2004 · 83 employees$979.8Mraised▾
Mesoblast specializes in developing cellular medicines. The company has a clinically advanced and diverse portfolio of cell-based products with five programs, two of which are partnered, in active Phase 3 clinical studies or Phase 3-ready, and four programs in Phase 2. These clinical programs target therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The Japanese Government has approved TEMCELL® HS. Inj., a product based on their proprietary allogeneic mesenchymal lineage adult stem cell technology licensed to JCR Pharmaceuticals Co. Ltd for the treatment of graft versus host disease in children and adults in Japan. Their product candidate, MSC-100-IV, has orphan drug designation and is being developed under an accelerated regulatory approval pathway in line with the United States Food and Drug Administration (FDA) discussions for children with steroid-refractory acute graft versus host disease. Two other lead product candidates, MPC-150-IM and MPC-06-ID, are in late-stage development in Phase 3 programs targeting, respectively, advanced chronic heart failure and chronic low bac
- Jan 2025Post IPO$160M
- Apr 2023Post IPO—
- Aug 2022Post IPO$45M
- Mar 2021Post IPO$110M
#4
Series A · Carlton, Victoria · founded 2015$3.5Mraised▾
Provider of pain education and self-management strategy services
- Feb 2024Grant (prize money)$257.8K
- Mar 2023Series A$3.5M
#5
Acquired · Perth, Western Australia · founded 1984 · 7 employees$90.8Mraised▾
Developer of dermatology treatments for underserved skin diseases. It develops and commercializes treatments for common skin diseases and infections. The company focuses on bringing first-in-class treatments to market, adhering to high clinical standards. A multi-disciplinary team with expertise in dermatology, clinical research, and commercialization drives its efforts. The company has a mature pipeline of dermatology and antimicrobial products.
- Apr 2025Post IPO$25.6M
- Sep 2022Post IPO—
- Aug 2019Post IPO$40M
- Jun 2018Post IPO$3.9M
#6
Public · Melbourne, Victoria · founded 2021 · 18 employees$3Mraised▾
Provider of phase I & II clinical trial services for mental health diseases
- Apr 2026Post IPO$987.9K
- May 2025Post IPO$66.6K
- Apr 2025Post IPO$1.4M
- Apr 2025Post IPO$111.7K
#7
Series B · Melbourne, Victoria · founded 2019$15Mraised▾
Developer of an AI assistant designed for clinical documentation support. The AI transcribes visits, structures notes, and generates referrals. It also auto-applies codes and tasks, and sends information to electronic health records. The AI adapts to various clinical specialties and settings.
- Oct 2025Series B$65M
- Mar 2025Series A$16.6M
- Oct 2023Series A$10M
- Aug 2021Seed$5M
#8
Funding Raised · Brookvale, New South Wales · founded 2011 · 26 employees$32.9Mraised▾
Biointelect offers market evaluation and strategy design and development services for biopharmaceutical, medical device, and IVD companies. While for early stage companies they provide product development support through their commercial and market insights, for late stage companies they offer services for product planning, project startup and development and also in identifying the right commercial partners. Base on their expertise in market evaluation, they help clients in designing their clinical, regulatory, reimbursement and market-entry strategies.
- Jul 2025Grant (prize money)$32.9M
#9
Seed · Melbourne, Victoria · founded 2023 · 12 employees$24.3Mraised▾
Foundation focused on providing of accessible healthcare services
- Sep 2024Seed$13.5M
- Mar 2024Seed$8.2M
- May 2023Seed$2.7M
#10
Series B · Brisbane, Queensland · founded 2015 · 95 employees$25Mraised▾
Provider of human measurement technology, clinic, and health online webinar services
- Sep 2024PE—
- Nov 2022Series B$25M
#11
Seed · Brisbane, Queensland · founded 2024$1.6Mraised▾
Provider of whole-body magnetic resonance imaging scans and medical reviews. The company offers clinically reviewed, radiation-free scans, with doctor-explained results. It facilitates proactive health monitoring through baseline tracking. The service includes radiologist reports and follow-up consultations. The company partners with clinics to expand access to preventive scans.
- Aug 2025Seed$1.6M
#12
Public · Waterloo, New South Wales · founded 1987 · 41000 employees$792.2Mraised▾
In 2022, the company recorded annual revenues of $5.94B and a net profit of $0.7B.
- Jan 2019Post IPO$600M
- Oct 2017Conventional Debt$188M
- Feb 2007Post IPO$4.2M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.